Sign up to save your podcasts
Or
Share FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
By U.S. Food and Drug Administration, Center for Drug Evaluation and Research
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) is an FDA podcast series that provides information about new product approvals, emerging safety information for cancer treatments, and ... more
4.4
1414 ratings
FAQs about FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.):
How many episodes does FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) have?
The podcast currently has 126 episodes available.
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episodes:
January 17, 2025FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory acute graft versus host disease in pediatric patients 
December 30, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adults with advanced unresectable or metastatic pancreatic adenocarcinoma harboring a neuregulin 1 (NRG1) gene fusion with disease progression on or after prior s November 18, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma November 14, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for unresectable advanced or metastatic malignant pleural mesothelioma August 16, 2024FDA D.I.S.C.O. Burst Edition: FDA approvals of Augtyro (repotrectinib) for NTRK gene fusion-positive solid tumors and Krazati (adagrasib) for KRAS G12C-mutated colorectal cancer July 02, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Retevmo (selpercatinib) for advanced or metastatic RET fusion-positive thyroid cancer June 17, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation April 26, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2-positive solid tumors January 08, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of OGSIVEO (nirogacestat) for adult patients with progressing desmoid tumors who require systemic treatment January 05, 2024FDA D.I.S.C.O. Burst Edition: FDA approval of Augtyro (repotrectinib) for locally advanced or metastatic ROS1-positive non-small cell lung cancer
FAQs about FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.):
How many episodes does FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) have?
The podcast currently has 126 episodes available.